P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Detalles Bibliográficos
Autores principales: Hwang, Steven, Wang, Jacqueline, Tian, Zizhong, Qi, Xinyue, Jiang, Yi, Zhang, Shijia, Godby, Richard C., Parikh, Sameer, Ding, Wei, Hampel, Paul, Munoz, Javier, Paludo, Jonas, Kenderian, Saad, Muchtar, Eli, Tsang, Mazie, Hilal, Talal, Leis, Jose, Thanarajasingam, Gita, Inwards, David, Nowakowski, Grzegorz S., Ansell, Stephen, Habermann, Thomas, Witzig, Thomas, Kay, Neil, Zhou, Shouhao, Wang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428881/
http://dx.doi.org/10.1097/01.HS9.0000969432.47546.cf

Ejemplares similares

Ejemplares similares